Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Cenegermin by Dompe Farmaceutici for Keratoconjunctivitis Sicca (Dry Eye): Likelihood of Approval
Cenegermin is under clinical development by Dompe Farmaceutici and currently in Phase II for Keratoconjunctivitis Sicca (Dry Eye). According to...
Data Insights
Cenegermin by Dompe Farmaceutici for Sicca Syndrome (Sjogren): Likelihood of Approval
Cenegermin is under clinical development by Dompe Farmaceutici and currently in Phase III for Sicca Syndrome (Sjogren). According to GlobalData,...